November 3, 2025
Start2 Group today announces its partnership with the Biomedical Advanced Research and Development Authority (BARDA) to launch a new prize initiative focused on broad-spectrum small molecule antivirals.
May 16, 2024
Start2 Group, a global accelerator and startup ecosystem platform, is pleased to announce the launch of the Vaccine Innovation and Therapeutics Acceleration Launchpad (VITAL) Hub.
